StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) stock

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.98+0.19 (+1.28%)

Close on Nov 18, 2026Market cap $12.50BP/E 27.5Yield 0.57%

Dr Reddys Laboratories net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2026 it was ₹42.85B, down 24.2% from the year before. The highest annual figure on record is ₹56.54B in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2026Mar 31, 2026₹42.85B-24.2%
FY2025Mar 31, 2025₹56.54B+1.5%
FY2024Mar 31, 2024₹55.68B+23.6%
FY2023Mar 31, 2023₹45.07B+359.6%
FY2018Mar 31, 2018₹9.81B-18.5%
FY2017Mar 31, 2017₹12.04B-39.8%
FY2016Mar 31, 2016₹20.01B–

More Dr Reddys Laboratories figures

See a number that looks wrong?